Page last updated: 2024-08-24

5-bromo-4-chloro-3-indolyl beta-galactoside and Neurodegenerative Diseases

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, SR; Baxter, D; Carlson, G; Ebeling, C; Gunn, TM; Hood, LE; Jaques, B; LaPierre, S; Lee, I; Moon, TM; Schweitzer, KM; Silvius, D; Stephenson, DA; Wegner, M1

Other Studies

1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Neurodegenerative Diseases

ArticleYear
Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice.
    Mammalian genome : official journal of the International Mammalian Genome Society, 2015, Volume: 26, Issue:1-2

    Topics: Animals; Biosynthetic Pathways; DNA Mutational Analysis; DNA Primers; Galactosides; Gene Expression Profiling; Gene Expression Regulation; Humans; Indoles; Mice; Mice, Knockout; Mice, Mutant Strains; Microsatellite Repeats; Mutation, Missense; Myelin Sheath; Neurodegenerative Diseases; SOXE Transcription Factors

2015